Prescription drug list (formulary) — coverage criteria
Customize your policy alerts
Sign up for all SelectHealth policy alerts
Know when SelectHealth releases new policies or updates existing guidance.
Monitor payer policy activity
This document summarizes commonly prescribed drugs that SelectHealth covers, explains tiers, cost-sharing, and special requirements (preauthorization, step therapy, quantity limits, age limits) and directs members to the full online formulary and pharmacy services for details.
No material clinical or coverage changes in this revision.
Formulary Coverage Criteria
Formulary drug entries
Coverage entries show drug tier and any requirement flags (PA, ST, QL, AGE, M).
Full per‑drug clinical coverage criteria are not present in this excerpt.
Formulary coverage contingent on listed requirement flags
Coverage is determined by drug-specific tier plus fulfillment of listed requirement flags (e.g., PAJ, QL, M, AGE).
Specific clinical criteria for prior authorization or medical necessity are not included in this excerpt; refer to the full policy for detailed PA/M criteria.
Formulary coverage tokens
Coverage and management indicated by tier and requirement tokens
This listing shows tokenized requirement annotations per drug entry; numeric QL values and the detailed PA/M criteria are not present in these chunks.
Drugs that are not on the formulary are not covered unless a Drug Coverage Exception is granted. A request for exception must be submitted using the Drug Coverage Exception Form and include medical necessity justification; requests are decided on a case‑by‑case basis.
Within the excerpt provided there are no explicit exclusion conditions listed. The listing shows formulary entries with tier assignments and administrative requirement codes but does not state specific exclusion criteria in these chunks.
No explicit clinical exclusions are stated in this excerpt. Entries in the listing primarily convey drug tiers and Requirements & Limits tokens (for example, PAJQL, QL, M, ST) adjacent to drug or device names rather than detailed clinical exclusion rules.
The document segments provided do not contain explicit exclusion statements. Instead, they show multiple drug and device entries with tier designations and management tokens (e.g., (PAJQL), (QL), (M), (ST)). Any exclusionary determinations are not present in these chunks.
There are no explicit 'not medically necessary' statements in the excerpted content. Some entries are annotated with (M) indicating medical necessity may be required for coverage, but the source does not include blanket 'not medically necessary' determinations in these chunks.
Within the provided chunks there are no explicit 'not medically necessary' determinations. The listing uses markers such as (M) to indicate that medical necessity documentation may be required for specific products, but no product is identified here as categorically not medically necessary.
Requirement Codes and Tokens
| PAJ | Prior authorization (document shorthand) |
| QL | Quantity limit |
| M | Medical necessity |
| AGE | Age limit |
| STHQL | Step therapy / prior step edit with QL (document shorthand) |
| STJQL | Step therapy indicator with QL (document shorthand) |
| PAJQL | Requirements & Limits code appearing on multiple items |
| QL | Quantity limit annotation |
| M | Medical necessity annotation |
| ST | Step therapy annotation |
| AGE | Age limit annotation header repeated in excerpt |
| PAJ(QL)(M) | Variant combination of annotations |
| STJ(QL)(M) | Variant combination of annotations |
| PA | Prior Authorization |
| PAJQL | Compound prior auth/quantity limit/j code/M indicator (document uses combined token) |
| QL | Quantity Limit |
| M | May indicate medical management or specialty handling (document token 'M') |
| ST | Step Therapy |
| STH | Step Therapy H variant |
| STJ | Step Therapy J variant |
Provider Actions, Prior Authorization & Documentation
Prior authorization required
Certain specialty or high‑tier drugs require prior authorization (PA) before they will be covered. Drugs annotated with PA, PAJQL, PAJ, or similar codes in the formulary indicate PA is required — failure to obtain PA may result in claim denial or the member being responsible for full retail cost.
- Examples: oncology, specialty injectables, and select high‑tier branded products noted with (PA) or (PAJQL).
- Mounjaro Injectable specifically listed with (PAJQL)(M) — PA plus medical necessity documentation required at initiation.
Prior authorization required for many test supplies
Many test supplies and devices (blood glucose meters, test strips, syringes, etc.) carry PA or PAJQL flags. Prior authorization and documentation of medical necessity, quantity limits, and age may be required for coverage of these supplies.
- Examples: multiple glucose test kits and syringe items listed with (PAJQL)(M) or (PAJQL).
- 60mL, 140mL syringes and many meter/test kit SKUs appear with PA/PAJQL annotations.
Prior authorization required for select injectables
Some injectable products are subject to prior authorization. Look for (PA) or compound PA codes beside injectable entries — these require PA before dispensing to avoid coverage denial.
- Example: Certain injectables and specialty biologics in the formulary are annotated with (PA).
Step therapy requirement
Step therapy (ST, STH, STJ, STJQL and related flags) requires that specified alternate therapy be tried and fail before the requested drug will be covered. Failure to meet step requirements may prevent coverage.
- Step therapy commonly applies to brand‑name drugs and some device/supply bundles.
- Entries show ST, STH, STJ, STJQL — treat these as step edits requiring prior step(s).
Potential triggers for denial
Formulary Requirement & Limits codes such as PAJQL, PA, QL, ST, M, and AGE can trigger prior authorization requests, quantity limit denials, step edits, or age‑based coverage restrictions. When these flags appear on a product, verify PA/criteria and supporting documentation before dispensing.
- PAJQL / PAJ indicate PA is required and may result in coverage denial if not obtained.
- QL flags indicate quantity limits; exceeding QL typically needs PA.
- AGE flags indicate age restrictions — age must be documented at adjudication.
Documentation for PA / medical‑necessity requirements
When entries include (M) or compound codes like (PAJQL)(M), medical necessity documentation is expected at PA initiation and/or ongoing coverage review. Provide clinical notes, prior medication history, and rationale for therapy to support PA requests.
- M = medical necessity documentation required.
- Products like Mounjaro list (PAJQL)(M) — both PA and medical justification are required.
Documentation expectations
Providers should be prepared to supply supporting documentation for step edits, PA criteria, quantity limits, and age restrictions. Include patient age, prior therapy trials, dosing history, clinical notes, and any relevant lab results with the PA submission to avoid processing delays or denials.
- Age‑restricted items (AGE) require age verification in the documentation.
- Step therapy flags (ST, STH, STJ) require documentation of prior trial(s) and reasons for failure.
Noncovered drug exception process
Noncovered drugs may be considered via a Drug Coverage Exception; the Drug Coverage Exception Form on SelectHealth's website must be used to request coverage based on medical necessity. Requests are reviewed case‑by‑case.
- Use the Drug Coverage Exception Form found on the SelectHealth website.
- Decisions are made based on submitted medical necessity documentation.
Pharmacy Services contact
Contact SelectHealth Pharmacy Services to verify coverage rules, PA requirements, and member benefits before prescribing or dispensing. SelectHealth members and providers may call Pharmacy Services at 800‑538‑5038 for assistance.
- Pharmacy Services can confirm formulary status, PA needs, and member cost‑sharing.
- Have NDC, strength, quantity, and clinical rationale available when calling.
Legend and Definitions
The formulary groups medications by therapeutic categories and into drug tiers to guide coverage and member cost‑sharing. A clinical review team of physicians and pharmacists evaluates drugs regularly (monthly) for efficacy, safety, and cost‑effectiveness, which can result in additions or removals from the formulary. The excerpted listing shows each drug or device with its drug tier and any adjacent Requirements & Limits tokens (examples: (PAJQL), (QL), (M), (ST)) that determine whether additional actions—such as prior authorization, adherence to quantity limits, step therapy, or age documentation—are required for coverage.
Step Therapy Requirements
| Drug / Item | Requirement token | Notes |
|---|---|---|
| {"text":"Adapalene Gel","status":""},{"text":"ST","status":""},{"text":"Listed with (ST) indicating step therapy is required before coverage","status":""} | ||
| {"text":"Clindamy/Ben Gel","status":""},{"text":"ST","status":""},{"text":"Marked (ST) in Requirements & Limits","status":""} | ||
| {"text":"Dapsone","status":""},{"text":"ST","status":""},{"text":"Entry shows (ST) indicating step therapy requirement","status":""} | ||
| {"text":"Auvi-Q Injectable","status":""},{"text":"QL","status":""},{"text":"Although shown with (QL), nearby legend and entries indicate ST applies to some anaphylaxis agents; include for context","status":""} |
| Drug / Item | Indicator token | Interpretation |
|---|---|---|
| {"text":"Dofetilide Capsule","status":""},{"text":"STHQL","status":""},{"text":"Listed with (STHQL) indicating a step therapy edit combined with QL in Requirements & Limits","status":""} | ||
| {"text":"Icosapent Capsule","status":""},{"text":"STJQL","status":""},{"text":"Marked (STJQL) showing a step therapy indicator variant combined with quantity limit","status":""} | ||
| {"text":"Nicotine (Ra Nicotine variant)","status":""},{"text":"STHQL","status":""},{"text":"Nicotine products include (STHQL) on some SKUs indicating hierarchical step/QL constraints","status":""} |
| Device / Supply | Step token present | Coverage implication |
|---|---|---|
| {"text":"Assure 3 Tes","status":""},{"text":"STJ","status":""},{"text":"Requirements & Limits include STJ (and QL/AGE/M variants) indicating step controls before coverage","status":""} | ||
| {"text":"Easy Trak Tes / Easy Trak Ii Tes","status":""},{"text":"STJ","status":""},{"text":"Entries show STJ(QL)(AGE)(M) variants — step therapy controls apply to these test supplies","status":""} | ||
| {"text":"Easy Talk Tes","status":""},{"text":"ST","status":""},{"text":"One listing shows (ST)QL)(M) marking step therapy plus quantity/medical limits","status":""} |
| Example product | Attached step token(s) | Meaning in list |
|---|---|---|
| {"text":"Lansoprazole","status":""},{"text":"STH","status":""},{"text":"Entry includes (STH(QL)(AGE)(M)) variant — shows STH step-therapy variant is applied with QL/AGE/M modifiers","status":""} | ||
| {"text":"Easy Touch / Easy Max Glc Tes","status":""},{"text":"ST / STJ","status":""},{"text":"Multiple glucose test device entries include ST or STJ tokens combined with PAJQL and M annotations","status":""} | ||
| {"text":"Topamax Spr Capsule","status":""},{"text":"ST","status":""},{"text":"Marked (ST)QL)(M) indicating step therapy requirement for this product","status":""} |
| Product / Group | Marking | Policy statement |
|---|---|---|
| {"text":"General step-therapy flag (legend)","status":""},{"text":"ST","status":""},{"text":"(ST) denotes step therapy: coverage only after trial and failure of an alternative therapy","status":""} | ||
| {"text":"Selected antiepileptic entries (e.g., Topamax Spr Capsule)","status":""},{"text":"ST","status":""},{"text":"Products labeled (ST) require completion of step therapy prior to coverage","status":""} | ||
| {"text":"Nicotine cessation SKUs","status":""},{"text":"STH","status":""},{"text":"Some nicotine products include (STH) / (STHQL) indicating hierarchical step edits possibly combined with QL/AGE modifiers","status":""} |
| Product / Category | Token shown | Constraint type |
|---|---|---|
| {"text":"Ra Nicotine (selected SKUs)","status":""},{"text":"STHQL","status":""},{"text":"Indicates hierarchical step therapy combined with quantity limit and other modifiers for nicotine/cessation products","status":""} | ||
| {"text":"Qc Nicotine Dis","status":""},{"text":"PAJQL / M","status":""},{"text":"Some nicotine products shown with (PAJQL)M or (STHQL) reflecting combined step/PA/QL/medical requirements","status":""} | ||
| {"text":"Chantix Tablet","status":""},{"text":"QLJMJAGE","status":""},{"text":"Smoking cessation product shows QL and age constraints in Requirements & Limits (QL/J/M/AGE tokens) — hierarchical controls apply","status":""} |
Quantity Limits and Examples
Policy Revision History
Formulary effective date updated to 2025-10-01; formulary content is current as of this date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.